课题基金 / 基金详情

项目摘要

项目成果

Fang Li的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):病毒对受体的识别是病毒感染的第一步,也是必不可少的一步。它是病毒宿主范围和跨物种感染的重要决定因素,也是人类干预的主要目标。冠状病毒识别多种受体,感染许多宿主,对人类和其他动物的健康构成重大威胁。NL63冠状病毒(NL63-CoV)是一种流行的人类呼吸道病毒,是目前已知的唯一一种以血管紧张素转换酶2(ACE2)为受体的I型冠状病毒,而其他I型冠状病毒则以氨基肽酶-N(APN)为受体。奇怪的是,ACE2也被第二组SARS冠状病毒(SARS-CoV)使用,SARS-CoV是致命的人类严重急性呼吸综合征(SARS)的制剂。NL63-CoV和SARS-CoV刺突蛋白上定义的受体结合域与ACE2具有高亲和力。本研究探讨冠状病毒的受体识别机制和跨物种感染。我们的初步研究确定了NL63冠状病毒RBD与人ACE2的络合物和SARS冠状病毒RBD与人ACE2的络合物的晶体结构。NL63-CoV和SARS-CoV rbd在直接与ACE2接触的核心或受体结合基序(RBM)上没有结构上的同源性,但识别ACE2上的相同“病毒结合热点”。在I组冠状病毒中,RBD核心是保守的,但RBM是可变的,这解释了这些病毒如何识别不同的受体。我们还测定了SARS冠状病毒不同毒株与人和果子狸ACE2蛋白的RBD的晶体结构,揭示了SARS冠状病毒在两种宿主之间传播的机制。这个项目有三个具体目标。目的1研究I组NL63冠状病毒的受体识别机制。它研究了人ACE2上的病毒结合热点在NL63-CoV结合中的特定功能,并检测了NL63-CoV刺突蛋白与非人类宿主ACE2蛋白之间的相互作用。目的研究其他I组冠状病毒的受体识别机制。它研究了其他I组冠状病毒S蛋白的RBM的特定功能,并研究了修饰RBM是否改变了S蛋白的受体特异性。目的研究第二组SARS冠状病毒的受体识别机制。它调查了为什么选择过去SARS-CoV毒株的RBM区域的突变,这些突变是否以及如何影响受体结合,以及这些突变的什么组合可能出现在未来的SARS-CoV潜在毒株中。这一建议的研究方法包括对病毒-受体界面的结晶学分析,对病毒-受体相互作用重要的结构元件的鉴定,以及使用结晶学、生化、分子和病毒学工具对这些元件进行表征。总体而言,这些研究将为了解病毒进化、病毒-受体相互作用、病毒宿主范围和跨物种感染提供分子和结构基础。它们还将指导开发针对冠状病毒感染的新型抗病毒策略。 公共卫生相关性:这项研究调查了冠状病毒如何识别它们的受体,以及它们如何与来自不同宿主的受体相互作用。它探索了管理病毒进化、病毒-受体相互作用、病毒宿主范围和跨物种感染的新原理,并可能导致预防和治疗人类和其他动物冠状病毒感染的新方法。
英文摘要
DESCRIPTION (provided by applicant): Receptor recognition by viruses is the first and essential step of viral infections. It is an important determinant of viral host ranges and cross-species infections, and a primary target for human intervention. Coronaviruses recognize a variety of receptors, infect many hosts, and are significant health threats to humans and other animals. NL63 coronavirus (NL63-CoV), a prevalent human respiratory virus, is the only group-I coronavirus known to use angiotensin-converting enzyme 2 (ACE2) as its receptor, whereas other group-I coronaviruses use aminopeptidase-N (APN). Curiously, ACE2 is also used by group-II SARS coronavirus (SARS-CoV), the agent for the fatal human severe acute respiratory syndrome (SARS). Defined receptor-binding domains (RBDs) on the spike proteins of NL63-CoV and SARS-CoV bind ACE2 with high affinity. This research investigates the receptor recognition mechanisms and cross-species infections of coronaviruses. Our preliminary studies have determined the crystal structures of NL63-CoV RBD complexed with human ACE2 and of SARS-CoV RBD complexed with human ACE2. NL63-CoV and SARS-CoV RBDs have no structural homology in cores or receptor-binding motifs (RBMs) that directly contact ACE2, but recognize the same "virus-binding hotspot" on ACE2. Among group-I coronaviruses, RBD cores are conserved, but RBMs are variable, explaining how these viruses recognize different receptors. We have also determined crystal structures of the RBDs from various SARS-CoV strains complexed with ACE2 proteins from humans and palm civets, revealing mechanisms whereby SARS-CoV transmitted between the two hosts. There are three specific aims in this project. Aim 1 focuses on the receptor recognition mechanisms of group-I NL63-CoV. It investigates specific functions of the virus-binding hotspot on human ACE2 in NL63-CoV binding, and examines interactions between the NL63-CoV spike protein and ACE2 proteins from non-human hosts. Aim 2 focuses on the receptor recognition mechanisms of other group-I coronaviruses. It investigates specific functions of the RBMs of other group-I coronavirus spike proteins, and studies whether modifying the RBMs changes the receptor specificities of the spike proteins. Aim 3 focuses on the receptor recognition mechanisms of group-II SARS-CoV. It investigates why mutations in the RBM region of past SARS-CoV strains were selected, whether and how these mutations affect receptor binding, and what combinations of these mutations may appear in potential future SARS-CoV strains. The research approaches of this proposal include crystallographic analysis of the virus-receptor interfaces, identification of structural elements important for virus-receptor interactions, and characterization of these elements using crystallographic, biochemical, molecular, and virological tools. Overall, these studies will provide the molecular and structural basis for understanding viral evolution, virus-receptor interactions, viral host ranges and cross-species infections. They will also guide the development of novel antiviral strategies against coronavirus infections. PUBLIC HEALTH RELEVANCE: This research investigates how coronaviruses recognize their receptors and how they interact with receptors from different hosts. It explores novel principles governing viral evolution, virus-receptor interactions, viral host ranges and cross-species infections, and may lead to new approaches in the prevention and treatment of coronavirus infections in humans and other animals.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting ATM to boost systemic effects of radiotherapy and immunotherapy
  • 批准号:
    10586034
  • 项目类别:
  • 资助金额:
    $51.6万
  • 财政年份:
    2021
  • 负责人:
    Fang Li
  • 依托单位:
Targeting apoptotic caspases to enhance cancer radiotherapy
  • 批准号:
    10305613
  • 项目类别:
  • 资助金额:
    $45.84万
  • 财政年份:
    2017
  • 负责人:
    Fang Li
  • 依托单位:
Necroptotic genes in cancer cellular response to radiation
  • 批准号:
    10089416
  • 项目类别:
  • 资助金额:
    $44.3万
  • 财政年份:
    2017
  • 负责人:
    Fang Li
  • 依托单位:
Receptor recognition and cell entry of coronaviruses
  • 批准号:
    9174759
  • 项目类别:
  • 资助金额:
    $46.44万
  • 财政年份:
    2016
  • 负责人:
    Fang Li
  • 依托单位:
海外基金